Group 1 - The core viewpoint of the article highlights that Yidu Tech (02158.HK) has demonstrated strong confidence in its long-term value and the prospects of the AI healthcare industry through its recent share buybacks, totaling over 76 million HKD this year [1] - On February 27, Yidu Tech repurchased 322,000 shares at approximately 5.99 HKD per share, with a total expenditure of nearly 2 million HKD [1] - As of February 27, 2026, Yidu Tech's stock closed at 5.97 HKD, reflecting a 0.84% increase, with a trading volume of 3.8013 million shares and a turnover of 22.7438 million HKD [1] Group 2 - The investment banks predominantly rate Yidu Tech as outperforming the industry, with one bank issuing an outperform rating in the last 90 days and a target average price of 6.8 HKD [1] - CICC's latest report also assigns an outperform rating to Yidu Tech, with a target price set at 6.8 HKD [1] - Yidu Tech's market capitalization stands at 6.212 billion HKD, ranking 10th in the healthcare services sector [1]
医渡科技(02158.HK)2月27日再回购近200万港元 获中航证券重点推荐